Modern Dental Group Limited (HKG:3600)
Hong Kong · Delayed Price · Currency is HKD 5.38
+0.06 (1.13%)
Sep 5, 2025, 4:08 PM HKT
Modern Dental Group Revenue
Modern Dental Group had revenue of 1.83B HKD in the half year ending June 30, 2025, with 14.56% growth. This brings the company's revenue in the last twelve months to 3.50B, up 6.87% year-over-year. In the year 2024, Modern Dental Group had annual revenue of 3.36B with 6.05% growth.
Revenue (ttm)
3.50B
Revenue Growth
+6.87%
P/S Ratio
1.42
Revenue / Employee
406.91K
Employees
7,106
Market Cap
4.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.36B | 191.97M | 6.05% |
| Dec 31, 2023 | 3.17B | 341.96M | 12.08% |
| Dec 31, 2022 | 2.83B | -125.08M | -4.23% |
| Dec 31, 2021 | 2.96B | 764.96M | 34.93% |
| Dec 31, 2020 | 2.19B | -209.34M | -8.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 35.81B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| Sino Biopharmaceutical | 33.49B |
| WuXi Biologics | 21.98B |
| Akeso | 2.75B |
| CSPC Pharmaceutical Group | 28.49B |
Modern Dental Group News
- 5 months ago - How two Hong Kong firms’ innovative solutions enhance well-being in belt and road regions - South China Morning Post